Clinical Trial Update: The Use of Dual Chamber ICD With Special Programmed Features to Lower the Risk of Inappropriate Shock [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a dual-chamber implantable cardioverter-defibrillator with specialized programming features aimed at reducing inappropriate sh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Supraventricular Tachycardia
• Ventricular Fibrillation
• Ventricular Tachycardia

Snippet

Sponsor: Mayo Clinic | Conditions: Ventricular Tachycardia, Ventricular Fibrillation | Phase 4 | Status: COMPLETED | Results posted: 2014-06-11